Cargando…
Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis
BACKGROUND: Approximately 6 million people worldwide are affected by Chagas disease, with many in the chronic phase of the disease (CCD). It is crucial to evaluate the effectiveness of benznidazole for CCD treatment. METHODS/PRINCIPAL FINDINGS: We updated a meta-analysis published in 2009 up to Febr...
Autores principales: | Crespillo-Andújar, Clara, Comeche, Belén, Hamer, Davidson H., Arevalo-Rodriguez, Ingrid, Alvarez-Díaz, Noelia, Zamora, Javier, Pérez-Molina, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135346/ https://www.ncbi.nlm.nih.gov/pubmed/35576215 http://dx.doi.org/10.1371/journal.pntd.0010386 |
Ejemplares similares
-
Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023) -
The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019) -
Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019) -
Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
por: Aguilera, Elena, et al.
Publicado: (2018) -
Efficacy of the Benznidazole+Posaconazole combination therapy in
parasitemia reduction: An experimental murine model of acute
Chagas
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)